Rianne van Gageldonk-Lafeber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rianne van Gageldonk-Lafeber has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Adam Meijer
National Institute for Public Health and the Environment, Bilthoven, The Netherlands
1 shared publication - Björn F. Koel
Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands
1 shared publication - Dirk Eggink
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
1 shared publication - Gabriel Goderski
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
1 shared publication Mariam Bagheri
Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
1 shared publication- Mariëtte Hooiveld
Netherlands Institute for Health Services Research (NIVEL), Utrecht, the Netherlands
1 shared publication
Latest Publications
- Open Access
- 10 September 2026
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 31 (36) , 2600733
Emergence and spread of NA-I223V and NA-S247N double-mutant A(H1N1)pdm09 influenza viruses with reduced oseltamivir susceptibility in the Netherlands and beyond, 2023 to 2026
In 2023/24, A(H1N1)pdm09 influenza viruses with neuraminidase (NA)-S247N emerged in NA-clade C.5.3.3 carrying NA-I223V, spread internationally, then faded. Such double mutants reappeared sporadically in 2024/25. They expanded again in 2025/26 in NA-clade D.3 viruses carrying NA-S247N after acquiring NA-I223V in Europe – notably Spain, the Netherlands, Finland and France, and beyond. Dutch double mutants from both seasons showed median 12- and 13-fold reduced inhibition by oseltamivir. These findings underscore the need for ongoing genomic and phenotypic monitoring of antiviral susceptibility.
- 10 September 2026
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 31 (36) , 2600733
Open AccessEmergence and spread of NA-I223V and NA-S247N double-mutant A(H1N1)pdm09 influenza viruses with reduced oseltamivir susceptibility in the Netherlands and beyond, 2023 to 2026
In 2023/24, A(H1N1)pdm09 influenza viruses with neuraminidase (NA)-S247N emerged in NA-clade C.5.3.3 carrying NA-I223V, spread internationally, then faded. Such double mutants reappeared sporadically in 2024/25. They expanded again in 2025/26 in NA-clade D.3 viruses carrying NA-S247N after acquiring NA-I223V in Europe – notably Spain, the Netherlands, Finland and France, and beyond. Dutch double mutants from both seasons showed median 12- and 13-fold reduced inhibition by oseltamivir. These findings underscore the need for ongoing genomic and phenotypic monitoring of antiviral susceptibility.